Glycemic self-monitoring and insurance coverage
Open Access
- 6 July 2004
- journal article
- editorial
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 171 (1) , 48-49
Abstract
Issue concerns the role of proton pump inhibitors (PPIs) in promoting CDAD. Other factors that elevate the risk of CDAD include older age, recent gastrointestinal surgery and immunocompromising therapy. The use of PPIs may augment these risks in such patients. Many infection control measures have been implemented, including contact precautions, dedicated equipment for infected patients when possible, disposable thermometers, early empirical treatment of suspected cases, infection prevention and control education for personnel, an emphasis on hand hygiene, intensified housekeeping in high-incidence units, sporicidal agents for environmental disinfection, review and potential restriction of antibiotics, and decreased turnaround time for C. difficile test results. Despite these measures, no hospital in our group has been able to bring the CDAD rate to its pre-epidemic rate. Why have we not been able to break the cycle of transmission? Several obstacles hamper control measures. In an outbreak situation, spore burdens are high and require increasing intensity of environmental disinfection. In most hospitals, the housekeeping staff was already working at full capacity before the outbreak. Overburdened health care workers have had difficulty coping with the increased numbers of patients in isolation. Inadequate numbers of single rooms with dedicated bathroom facilities also facilitate transmission. Let us remember that other infectious patients also require vigilant isolation, such as those with MRSA, VRE, measles, chicken pox and tuberculosis, to name a few. The paucity of adequate handwashing facilities further compounds the problem. Improved methods to monitor antibiotic utilization are required. Taken together, this highlights the lack of surge capacity to fully combat the outbreak. A number of unanswered questions remain. If this current strain is different, where has it come from? Why do some infected patients have serious complications, while other seemingly similar patients experience a relatively benign course? How can we prevent the occurrence of severe complications? The answers to these questions would improve our understanding of this disease and its control. It is only through a concerted and coordinated approach, coupled with increased resources and funding, that expeditious answers will be found to the current dilemma and patient safety will be assured.Keywords
This publication has 16 references indexed in Scilit:
- Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetesCanadian Medical Association Journal, 2004
- Clinician identification of chronically ill patients who have problems paying for prescription medicationsThe American Journal of Medicine, 2004
- Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of CareMedical Care, 2004
- Patient-Physician Communication About Out-of-Pocket CostsJAMA, 2003
- The Economic Cost of Diabetes in Canada, 1998Diabetes Care, 2002
- Self-restriction of medications due to cost in seniors without prescription coverage.2001
- The Impact of Blood Glucose Self-Monitoring on Metabolic Control and Quality of Life in Type 2 Diabetic PatientsDiabetes Care, 2001
- Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly PersonsJAMA, 2001
- Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing HomesNew England Journal of Medicine, 1991
- Payment Restrictions for Prescription Drugs under MedicaidNew England Journal of Medicine, 1987